Corticosteroid avoidance in adult kidney transplant recipients under rabbit anti-T-lymphocyte globulin, mycophenolate mofetil and delayed cyclosporine microemulsion introduction

Transplant International

Volumn 23, Issue 3, 2010, Pages 313-324

  Cantarovich, Diego ^a   Rostaing, Lionel ^b   Kamar, Nassim ^b   Saint Hillier, Yves ^c   Ducloux, Didier ^c   Mourad, Georges ^d   Garrigue, Valérie ^d   Wolf, Philippe ^e   Ellero, Bernard ^e   Cassuto, Elizabeth ^f   Albano, Laetitia ^f   Soulillou, Jean Paul ^a  

^a NANTES UNIVERSITY HOSPITAL   (France)

^b CHU RANGUEIL   (France)

^c HÔPITAL SAINT JACQUES   (France)

^d LAPEYRONIE HOSPITAL   (France)

^e HÔPITAL DE HAUTEPIERRE   (France)

^f PASTEUR HOSPITAL   (France)

Author keywords

Calcineurin inhibitors; Induction therapy and anti T lymphocyte globulin; Kidney transplantation; Mycophenolate mofetil; Rejection episodes; Steroid avoidance

Indexed keywords

CORTICOSTEROID; CYCLOSPORIN A; GANCICLOVIR; LYMPHOCYTE ANTIBODY; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; PREDNISONE; RAPAMYCIN; TACROLIMUS; VALACICLOVIR;

ACUTE GRAFT REJECTION; ADOLESCENT; ADULT; AGED; ARTICLE; BIOPSY; BRAIN HEMORRHAGE; CADAVER KIDNEY; CLINICAL TRIAL; COLD ISCHEMIA; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; CYTOMEGALOVIRUS INFECTION; DIABETES MELLITUS; DISEASE SEVERITY; DYSLIPIDEMIA; FEMALE; FEVER; FOLLOW UP; GRAFT RECIPIENT; HEART INFARCTION; HUMAN; HYPERTENSION; HYPOTENSION; KIDNEY TRANSPLANTATION; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; MICROEMULSION; MULTICENTER STUDY; MULTIPLE ORGAN FAILURE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEINURIA; RABBIT; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; T LYMPHOCYTE; TACHYCARDIA; THERAPY EFFECT;

ADOLESCENT; ADRENAL CORTEX HORMONES; ADULT; AGED; ANIMALS; ANTILYMPHOCYTE SERUM; CYCLOSPORINE; EMULSIONS; FEMALE; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KAPLAN-MEIERS ESTIMATE; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; MYCOPHENOLIC ACID; PROSPECTIVE STUDIES; RABBITS; T-LYMPHOCYTES; YOUNG ADULT;

EID: 75149184520     PISSN: 09340874     EISSN: 14322277     Source Type: Journal    
DOI: 10.1111/j.1432-2277.2009.00971.x     Document Type: Article

References (39)

1. Soulillou JP, Cantarovich D, Le Mauff B, et al. Randomized controlled trial of a monoclonal antibody against the interleukin-2 receptor (33B3.1) as compared with rabbit antithymocyte globulin for prophylaxis against rejection of renal allografts. N Engl J Med 1990 322: 1175.
2. Giral M, Taddei C, Nguyen JM, et al. Single-center analysis of 468 first cadaveric kidney allografts with a uniform ATG-CsA sequential therapy. In: Cecka, Terasaki, eds. Clin Transplant. UCLA Tissue Typing Laboratory, LA, California, 1996: 257 264.
3. Halloran P, Mathew T, Tomlanovich S, Groth C, Hooftman L, Barker C. Mycophenolate mofetil in renal allograft recipients: a pooled efficacy analysis of three randomized, double-blind, clinical studies in prevention of rejection. The International Mycophenolate Mofetil Renal Transplant Study Groups. Transplantation 1997 63: 39.
4. Cantarovich D, Karam G, Giral-Classe M, et al. Randomized comparison of triple therapy and antithymocyte globulin induction treatment after simultaneous pancreas-kidney transplantation. Kidney Int 1998 54: 1351.
5. Brown MW, Forwell MA. Rejection reaction after stopping prednisolone in kidney transplant recipients taking cyclosporine. N Engl J Med 1986 314: 183.
6. Hricik DE, O'Toole MA, Schulak JA, Herson J. Steroid-free immunosuppression in cyclosporine-treated renal transplant recipients: a meta-analysis. J Am Soc Nephrol 1993 4: 1300.
7. Ratcliffe PJ, Dudley CR, Higgins RM, Firth JD, Smith B, Morris PJ. Randomised controlled trial of steroid withdrawal in renal transplant recipients receiving triple immunosuppression. Lancet 1996 348: 643.
8. Ahsan N, Hricik D, Matas A, et al. Prednisone withdrawal in kidney transplant recipients on cyclosporine and mycophenolate mofetil-a prospective randomized study. Steroid Withdrawal Study Group. Transplantation 1999 68: 1865.
9. Vanrenterghem Y, Lebranchu Y, Hené R, Oppenheimer F, Ekberg H. Double-blind comparison of two corticosteroid regimens plus mycophenolate mofetil and cyclosporine for prevention of acute renal allograft rejection. Transplantation 2000 70: 1352.
10. Vanrenterghem Y, van Hoff JP, Squifflet JP, et al. Minimization of immunosuppressive therapy after renl transplantation: results of a randomized controlled trial. Am J Transplant 2005 5: 87.
11. Vincenti F, Schena FP, Paraskevas S, Hauser IA, Walker RG, Grinyo J. A randomized, multicenter study of steroid avoidance, early steroid withdrawal or standard steroid therapy in kidney transplant recipients. FREEDOM Study Group. Am J Transplant 2008 8: 307.
12. Woodle ES, First MR, Pirsh J, Shihab F, Gaber AO, van Veldhuissen P. A prospective, randomized, double-blind, placebo-controlled multicenter trial comparing early (7 days) corticosteroid cessation versus long-term, low-dose corticosteroid therapy. Astellas Corticosteroid Withdrawal Study Group. Ann Surg 2008 248: 564.
13. Matas AJ. Minimization of steroids in kidney transplantation. Transpl Int 2009 22: 38.
14. Cantarovich D. Prevention of acute rejection with antithymocyte globulin (Thymoglobuline): its potential to reduce corticosteroids. J Nephrol 2004 8: S40.
15. Woodruff MF, Reid B, James K. Effects of antilymphocytic antibody and antibody fragments on human lymphocytes in vitro. Nature 1967 215: 591.
16. Monaco AP, Abbot WM, Othersen HB, et al. Antiserum to lymphocytes: prolonged survival of canine allografts. Science 1966 153: 1264.
17. Bonnefoy-Bérard N, Vincent C, Revillard JP. Antibodies against functional leukocyte surface molecules in polyclonal antilymphocyte and antithymocyte globulins. Transplantation 1991 51: 669.
18. Rebellato LM, Gross U, Verbanac KM, Thomas JM. A comprehensive definition of the major antibody specificities in polyclonal rabbit antithymocyte globulin. Transplantation 1994 57: 685.
19. Merion RM, Howell T, Bromberg JS. Partial T-cell activation and anergy induction by polyclonal antithymocyte globulin. Transplantation 1998 65: 1481.
20. Genestier L, Fournel S, Flacher M, Assossou O, Revillard JP, Bonnefoy-Berard N. Induction of Fas (Apo-1, CD95)-mediated apoptosis of activated lymphocytes by polyclonal antithymocyte globulins. Blood 1988 7: 2360.
21. Birkeland SA. Steroid-free immunosuppression after kidney transplantation with antithymocyte globulin induction and cyclosporine and mycophenolate mofetil maintenance therapy. Transplantation 1998 66: 1207.
22. Cantarovich D, Giral-Classe M, Hourmant M, et al. Prevention of acute rejection with antithymocyte globulin, avoiding corticosteroids, and delaying cyclosporin after renal transplantation. Nephrol Dial Transplant 2000 15: 1673.
23. Cantarovich D, Giral-Classe M, Hourmant M, et al. Low incidence of kidney rejection following simultaneous kidney-pancreas transplantation after antithymocyte globulin induction and in the absence of corticosteroids: results of a prospective pilot study in 28 consecutive cases. Transplantation 2000 69: 1505.
24. Ducloux D, Kazory A, Challier B, et al. Long-term toxicity of antithymocyte globulin induction may vary with choice of agent: a single-center retrospective study. Transplantation 2004 77: 1029.
25. Opelz G, Naujokat C, Daniel V, Terness P, Döhler B. Disassociation between risk of graft loss and risk of non-Hodgkin lymphoma with induction agents in renal transplant recipients. Transplantation 2006 81: 1227.
26. Solez K, Axelsen RA, Benediktsson H, et al. International standardization of criteria for the histologic diagnosis of renal allograft rejection: the Banff working classification of kidney transplant pathology. Kidney Int 1993 44: 411.
27. Rostaing L, Cantarovich D, Mourad G, et al. Corticosteroid-free immunosuppression with tacrolimus, mycophenolate mofetil, and daclizumab induction in renal transplantation. Transplantation 2005 79: 807.
28. Charpentier B, Rostaing L, Berthoux F, et al. A three-arm study comparing tacrolimus therapy with antithymocyte globulin induction therapy followed by tacrolimus or cyclosporineA in adult renal transplant recipients. Transplantation 2003 75: 844.
29. Gonwa T, Johnson C, Ahsan N, et al. Randomized trial of tacrolimus + mycophenolate mofetil or azathioprine versus cyclosporine + mycophenolate mofetil after cadaveric kidney transplantation: results at three years. Transplantation 2003 75: 2048.
30. Grinyo J, Vanrenterghem Y, Nashan B, et al. Association of four DNA polymorphisms with acute rejection after kidney transplantation. Transpl Int 2008 21: 879.
31. Grosse-Wilde H, Jakubowski HD, Eigler FW, Kuwert EK. In vitro immunoresponsiveness in recipients of cadaveric renal allograft during ATG therapy. Proc EDTA 1981 18: 481.
32. Brennan DC, Daller JA, Lake KD, Cibrik D, Del Castillo D. Rabbit antithymocyte globulin versus basiliximab in renal transplantation. N Engl J Med 2006 355: 1967.
33. Kliem V, Fricke l, Wollbrink T, Burg M, Radermacher J, Rohde F. Improvement in long-term renal graft survival due to CMV prophylaxis with oral ganciclovir: results of a randomized clinical trial. Am J Transplant 2008 8: 975.
34. Sinha SK, Todd SC, Hedrick JA, Speiser CL, Lambris JD, Tsoukas CD. Characterisation of the EBV/C3d receptor on the human jurkat T-cell line. J Immunol 1993 150: 5311.
35. Kyllönen LE, Eklund BH, Pesonen EJ, Salmela KT. Single bolus antithymocyte globulin versus basiliximab induction in kidney transplantation with cyclosporine triple immunosuppression: efficacy and safety. Transplantation 2007 84: 75.
36. Beiras-Fernandez A, Chappell D, Hammer C, Beiras A, Reichart B, Thein E. Impact of polyclonal anti-thymocyte globulins on the expression of adhesion and inflammation molecules after ischemia-reperfusion injury. Transplant Immunol 2009 20: 224.
37. Louis S, Audrain M, Cantarovich D, et al. Long-term cell monitoring of kidney recipients after antilymphocyte globulin induction with and without steroids. Transplantation 2007 83: 712.
38. Müller TF, Grebe SO, Neumann MC, et al. Persistent long-term changes in lymphocyte subsets induced by polyclonal antibodies. Transplantation 1997 64: 1432.
39. Lange H, Müller TF, Ebel H, et al. Immediate and long-term results of ATG induction therapy for delayed graft function compared to conventional therapy for immediate graft function. Transplant Int 1999 12: 2.